<DOC>
	<DOCNO>NCT02935335</DOCNO>
	<brief_summary>AME non-interventional , prospective , longitudinal multicenter study . This study aim measure relationship antimüllerian hormone serum level ( AMH ) , measure single fully automate assay ( Elecsys® ) initial dose Menopur® Highly Purified-human Menopausal Gonadotrophin ( HP-hMG ) 600 IU/mL prescribe infertile woman undergo first In Vitro Fertilization ( IVF ) /Intra Cytoplasmic Sperm Injection ( ICSI ) cycle current practice .</brief_summary>
	<brief_title>A Study Measure Relationship Between Antimüllerian Hormone Initial Dose Menopur®</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>Women age [ 1842 ] year . Both ovary present . Regular menstrual cycle presume ovulatory . Primary secondary infertility origin 12 month . Patient least one result antimüllerian hormone ( AMH ) measure Elecsys® available inclusion , perform past 12 month inclusion . Candidates eligible first IVF/ICSI cycle Menopur® HPhMG 600 IU/mL prescribed . Having receive oral write information study , without objection use his/her anonymized data , sign write Informed Consent Form . Major uterine ovarian morphological abnormality past ovarian surgery . Endometriosis stage III/IV . Polycystic ovarian syndrome . Major endocrine metabolic abnormality without treatment . Patient include interventional study assess treatment infertility .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>